KalVista Pharmaceuticals (KALV) Return on Capital Employed Growth (3y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4,853.00 |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | -4,838.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -4,838.00 |
| Apr 30, 2025 | -3,739.00 |
| Oct 31, 2024 | -7,780.00 |
| Jul 31, 2024 | -5,514.00 |
| Apr 30, 2024 | -5,612.00 |
| Jan 31, 2024 | -3,944.00 |
| Oct 31, 2023 | -1,944.00 |
| Jul 31, 2023 | -1,516.00 |
| Apr 30, 2023 | -1,715.00 |
| Jan 31, 2023 | -1,794.00 |
| Oct 31, 2022 | -3,069.00 |
| Jul 31, 2022 | -2,557.00 |
| Apr 30, 2022 | -1,902.00 |
| Jan 31, 2022 | -1,963.00 |
| Oct 31, 2021 | -467.00 |
| Jul 31, 2021 | 3,088.00 |
| Apr 30, 2021 | 948.00 |
| Jan 31, 2021 | 229.00 |
| Oct 31, 2020 | 1,435.00 |
| Jul 31, 2020 | 2,201.00 |
| Apr 30, 2020 | 2,232.00 |